The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount a strong immune response to one strain, leaving them ...
The field of cell and gene therapy has seen a wave of exciting advances in the past 12 months. Following the landmark approval of the first CRISPR-based cell therapy in late 2023, investigators ...
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor ...
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice that outlines new discoveries about the roles of calcium signaling, regulatory ...